Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 72NIH 14NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 24Leukemia 18Sarcoma 17Neuroblastoma 13Central Nervous System Neoplasms 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Hodgkin Disease 9Breast Neoplasms 9Brain Neoplasms 9Burkitt Lymphoma 7Malignant mesenchymal tumor 6Lymphoma, Large B-Cell, Diffuse 6Leukemia, Myeloid, Acute 6Leukemia, Monocytic, Acute 6Rhabdomyosarcoma 5Ovarian Neoplasms 5Multiple Myeloma 5Leukemia, Myelomonocytic, Acute 5Leukemia, Megakaryoblastic, Acute 5Leukemia, Erythroblastic, Acute 5Kidney Neoplasms 5Testicular Neoplasms 4Teratoma 4Neutropenia 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Lung Neoplasms 4Leukemia, Biphenotypic, Acute 4Endometrial Neoplasms 4Dendritic Cell Sarcoma, Interdigitating 4

Interventions

Rituximab 8Vincristine 5Doxorubicin 5Cyclophosphamide 5Methotrexate 4Cytarabine 4Bortezomib 4Radiotherapy 3Prednisone 3Bendamustine Hydrochloride 3Peripheral Blood Stem Cell Transplantation 2Melphalan 2Leucovorin 2Dexamethasone 2CT-P10 2zanubrutinib 1obinutuzumab 1merphos 1liposomal amphotericin B 1ixabepilone 1ibritumomab tiuxetan 1fludarabine phosphate 1carmustine, poliferprosan 20 drug combination 1alvocidib 1acalabrutinib 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Tazobactam 1Tacrolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Lymphoma, Mantle-Cell × Filgrastim × Clear all
NCT00041132 2012-11-01

S0213 Chemotherapy Plus Rituximab in Treating Patients With Mantle Cell Lymphoma

SWOG Cancer Research Network

Phase 2 Completed
56 enrolled 9 charts
Lymphoid

Lymphoma, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡